High Rate of Pathologic Upgrading at Nephroureterectomy for Upper Tract Urothelial Carcinoma
Authors:
- Matthew K. TollefsonMTMatthew K. Tollefson
- Amy E. KrambeckAKAmy E. Krambeck
- Landon W. TrostLTLandon W. Trost
- R. Houston ThompsonRTR. Houston Thompson
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Upper tract urothelial carcinoma: Impact of time to surgeryUrologic Oncology: Seminars and Original Investigations, 2012
- Long-term Outcomes of Immediate Versus Delayed Nephroureterectomy for Upper Tract Urothelial CarcinomaJournal of Endourology, 2012
- Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tractBJU International, 2008
- Imperative Indications for Conservative Management of Upper Tract Transitional Cell CarcinomaJournal of Urology, 2007
- Ability of Clinical Grade to Predict Final Pathologic Stage in Upper Urinary Tract Transitional Cell Carcinoma: Implications for TherapyUrology, 2007
- Predictive Factors for Applicability and Success With Endoscopic Treatment of Upper Tract Urothelial CarcinomaJournal of Urology, 2003
- Conservative Elective Treatment of Upper Urinary Tract Tumors: A Multivariate Analysis of Prognostic Factors For Recurrence and ProgressionJournal of Urology, 2003
- URETEROSCOPIC MANAGEMENT OF UPPER TRACT TRANSITIONAL CELL CARCINOMA IN PATIENTS WITH NORMAL CONTRALATERAL KIDNEYSJournal of Urology, 2000
- Ureteroscopic Treatment and Surveillance of Upper Urinary Tract Transitional Cell CarcinomaJournal of Urology, 1997
- Diagnostic Accuracy of Ureteroscopic Biopsy in Upper Tract Transitional Cell CarcinomaJournal of Urology, 1997